Overview

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Status:
Terminated

Trial end date:
2011-11-17

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, multi-center, phase 4 study designed to compare intravenous (IV) daptomycin and IV vancomycin administered in a home infusion setting for the treatment of complicated skin and skin structure infections (cSSSI) due to Gram-positive bacteria in participants who are prescribed vancomycin for 7 to 14 days and who are planning to receive vancomycin in a home-infusion setting.

Phase:

Phase 4

Details

Lead Sponsor:

Cubist Pharmaceuticals LLC

Treatments:

Daptomycin
Vancomycin